(LifeSiteNews) – Planned Parenthood Great Northwest, Hawaii, Alaska, Indiana, Kentucky (PPGNHAIK) is offering an option for non-pregnant women to obtain abortion pills in advance and stockpile them for future use.

The affiliate, which covers Alaska, Hawaii, Idaho, Indiana, Kentucky, and western Washington state, announced the initiative, dubbed “Just In Case Abortion Pills,” which can be obtained by in-person or remote appointments, officially for use in the first 12 weeks of pregnancy. “If they become pregnant and decide to end that pregnancy, they already have the medication they need and can use it safely in the privacy of their own home,” PPGNHAIK says.

Pregnancy Help News reported that the program is first being rolled out in Hawaii and Washington, with the pills offered for $150 on their own or $100 with an appointment for other “services.” The pills currently do not qualify for insurance, but “financial assistance may be available for those who qualify.”

“At Planned Parenthood, we are committed to getting patients the care they need, when — and before — they need it,” affiliate CEO Rebecca Gibron declared. “We’re incredibly proud to be launching Just In Case Abortion Pills — the next step in making abortion care more accessible, more convenient, and more responsive to the realities of patients’ lives. When someone does not want to be pregnant, timing matters. Just In Case Abortion Pills gives that person the ability to act quickly and confidently.”

The “just in case scheme” effectively makes stockpiling abortion pills easier than stockpiling various toxic chemicals used in pest control. The federal government places various restrictions on the types and quantities of rodenticide included in commercially available rodent traps.

Mail-order abortion pills make chemical abortions even in pro-life states extremely difficult to prevent. The latest data from the pro-abortion Guttmacher Institute found 1,125,930 clinical abortions in 2025, a slight increase from 2024, which Guttmacher attributed in large part to abortion pills. Planned Parenthood’s 2024-2025 annual report boasts it alone committed 434,450 abortions, a record number for the organization and eight percent more than the previous year.

Abortion pills have become key to the abortion lobby’s effort to preserve “access” in a post-Roe v. Wade environment despite the risks to the women who take them.

Pro-lifers point to an April 2025 analysis by the Ethics & Public Policy Center (EPPC) that concluded almost 11% of women suffer sepsis, infection, hemorrhaging, or other major conditions after taking mifepristone, according to insurance data, plus similar findings by the Restoration of America Foundation as part of a “growing body of evidence” indicating that the health risks associated with mifepristone abortions are severe, widespread, and significantly underreported.

In May 2025, the Trump administration promised to review the safety data on abortion pills, giving hope for reversal of its stance, but nearly a year without updates has prompted frustration among pro-lifers, with Republican U.S. Sen. Josh Hawley of Missouri going so far as to question if the study is underway at all. Administration officials insist that review is still coming, though frustrated pro-lifers have argued a new official finding on the pills’ safety should not be necessary to restore enforcement of the federal law against mailing abortion pills across state lines.

The fight intensified last week when the U.S. Fifth Circuit Court of Appeals sided with Louisiana and temporarily blocked the FDA’s abortion pill rules, but the U.S. Supreme Court subsequently put a stay on that order while the justices consider the matter, allowing the pills to resume.